Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients
중환자 COVID-19 환자의 질병 중증도 지표로서의 피브로넥틴
Article
[키워드] Alter
APACHE II
Bacterial
Bacterial sepsis
Biomarker
Biomarkers
can be used
cellular
clinical setting
clinical settings
correlated
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 sample
COVID-19 samples
Critically ill
Critically ill patient
critically ill patients
disease severity
ELISA
etiology
expression of gene
Extracellular matrix
Fibronectin
form
help
Ill
immune response
immunoblotting
Infection
Intensive
intensive care
intensive care unit
knowledge
MONITOR
Mortality
mortality prediction
no significant difference
no significant differences
Non-survivors
outcomes
Patient
plasma
predict
Proteins
proteolytic
Research
SARS-CoV-2 virus
Sepsis
significantly higher
SOFA scores
treated
Treatment
Treatment outcome
Viral
was related
were measured
[DOI] 10.3390/cells11091566 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cells11091566 PMC 바로가기 [Article Type] Article